Lupin commissions new plantIllustrative image – not actual.

Lupin has commissioned its bulk drug manufacturing facility at Mandideep in Madhya Pradesh. The plant, which would manufacture bulk drug of Lisinopril and its other same class drugs, is expected to cater to US and European markets. The quantum of investment in the unit has not been disclosed.

← All latest storiesBack to top →